The real life impact of early versus delayed treatment of interferon beta on long-term disability progression in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Trojano, Maria
Amato, Maria Pia
Avolio, Carlo
Bergamaschi, Roberto
Cavalla, Paola
Durelli, Luca
Fuiani, Aurora
Ghezzi, Angelo
Lugaresi, Alessandra
Lus, Giacomo
Millefiorini, Enrico
Paolicelli, Damiano
Patti, Francesco
Pellegrini, Fabio
Imbaro, S. Maria
Pozzilli, Carlo
Rossi, Paolo
Salemi, Giuseppe
Vianello, Marica
Livrea, Paolo
Comi, Giancarlo
机构：
来源：
NEUROLOGY | 2008年 / 70卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A88 / A88
页数：1
相关论文
共 50 条
  • [1] Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
    Drulovic, Jelena
    Kostic, Jelena
    Mesaros, Sarlota
    Basuroski, Irena Dujmovic
    Stojsavljevic, Nebojsa
    Kisic-Tepavcevic, Darija
    Pekmezovic, Tatjana
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S65 - S69
  • [2] Impact of beta-interferon on disability progression in relapsing-remitting multiple sclerosis: a Bayesian analysis
    O'Rourke, K.
    Walsh, C.
    Hutchinson, M.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 102 - 103
  • [3] The impact of long-term treatment with disease modifying therapy on disability progression in relapsing-remitting multiple sclerosis patients
    Carra, Adriana J.
    Onaha, Patricia S.
    Sinay, Vladimiro
    Halfon, Mario J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S36 - S36
  • [4] Early prediction of the long-term response to interferon beta in relapsing-remitting multiple sclerosis patients
    Schmit, E.
    Gourraud, P. A.
    Couturier, N.
    Le Page, E.
    Vukusic, S.
    Debouverie, M.
    Defer, G. L.
    Lebrun, C.
    Frangoulis, B.
    Achiti, J.
    Merle, H.
    Edan, G.
    Fontaine, B.
    Clanet, M.
    Brassat, D.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S58 - S59
  • [5] Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis
    Portaccio, E
    Zipoli, V
    Siracusa, G
    Sorbi, S
    Amato, MP
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S158 - S158
  • [6] Long-term adherence to interferon β therapy in relapsing-remitting multiple sclerosis
    Portaccio, E.
    Zipoli, V.
    Siracusa, G.
    Sorbi, S.
    Amato, M. P.
    [J]. EUROPEAN NEUROLOGY, 2008, 59 (3-4) : 131 - 135
  • [7] Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
    Dekker, I
    Leurs, C. E.
    Hagens, M. H. J.
    van Kempen, Z. L. E.
    Kleerekooper, I
    Lissenberg-Witte, B., I
    Barkhof, F.
    Uitdehaag, B. M. J.
    Balk, L. J.
    Wattjes, M. P.
    Killestein, J.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 82 - 87
  • [8] Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis
    Greenberg, Benjamin M.
    Balcer, Laura
    Calabresi, Peter A.
    Cree, Bruce
    Cross, Anne
    Frohman, Teresa
    Gold, Ralf
    Havrdova, Eva
    Hemmer, Bernhard
    Kieseier, Bernd C.
    Lisak, Robert
    Miller, Aaron
    Racke, Michael K.
    Steinman, Lawrence
    Stuve, Olaf
    Wiendl, Heinz
    Frohman, Elliot
    [J]. JAMA NEUROLOGY, 2013, 70 (02) : 248 - 251
  • [9] Measuring disability progression: the impact of long-term treatment with disease-modifying therapy in relapsing-remitting multiple sclerosis patients
    Carra, A.
    Onaha, P.
    Schweitzer, L.
    Jullier, G. Imhoff
    Sinay, V.
    Vrech, C.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S248 - S248
  • [10] Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
    Shirani, Afsaneh
    Zhao, Yinshan
    Karim, Mohammad Ehsanul
    Evans, Charity
    Kingwell, Elaine
    van der Kop, Mia L.
    Oger, Joel
    Gustafson, Paul
    Petkau, John
    Tremlett, Helen
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (03): : 247 - 256
12345